Abstract:A sandwich enzymoimmunoassay (EIA) procedure was developed for the detection of HBsAg using Fab' of anti-HBsAg conjugated with beta-D-galactosidase from Escherichia coli with anti-HBsAg-coated silicone rubber discs as a solid phase. EIA could detect 1 ng/ml of HBsAg. It was as sensitive as radioimmunoassay (RIA, AusRia II) and about 30-fold more sensitive than reversed passive hemagglutination assay RPHA, ReverseCell). EIA and RIA could detect more HBsAg-positive sera than RPHA.
“…Serum C3 (70-176 mg/dl) and C4 (16-45 mg/ dl) were measured by radial immunodiffusion (14). Hepatitis B surFace antigen (15) and surface and core antibody (16) determinations were performed on sera from all patients and on the cryoprecipitates from 2 patients.…”
Two types of inflammatory vascular disease (IVD) occur in Sjogren's syndrome: neutrophilic IVD (NIVD) and mononuclear IVD (MIVD). In 45 patients with Sjogren's syndrome, we examined the 2 types of IVD with respect to serologic associations. NIVD, unlike MIVD, was significantly associated with seroreactivity reflected by hyperglobulinemia (P = 0.01), rheumatoid factor (P = 0.002), antinuclear antibodies (P = 0.02), and antibodies to Ro (SS-A) (P = 0.00006), and with hypocomplementemia (P = 0.03). The differential association of the 2 types of IVD with serologic reactivity and hypocomplementemia suggests that there may be basic differences in the immunopathogenesis of these 2 forms of IVD in Sjogren's syndrome.Inflammatory vascular disease (IVD) is increasingly being recognized as a complication of Sjogren's syndrome (SS) (1,2). Two distinct types of IVD have been observed (2): neutrophilic IVD (NIVD) and mononuclear IVD (MIVD). We previously reported a Publication #570 of the O'Neill Research Laboratories,
“…Serum C3 (70-176 mg/dl) and C4 (16-45 mg/ dl) were measured by radial immunodiffusion (14). Hepatitis B surFace antigen (15) and surface and core antibody (16) determinations were performed on sera from all patients and on the cryoprecipitates from 2 patients.…”
Two types of inflammatory vascular disease (IVD) occur in Sjogren's syndrome: neutrophilic IVD (NIVD) and mononuclear IVD (MIVD). In 45 patients with Sjogren's syndrome, we examined the 2 types of IVD with respect to serologic associations. NIVD, unlike MIVD, was significantly associated with seroreactivity reflected by hyperglobulinemia (P = 0.01), rheumatoid factor (P = 0.002), antinuclear antibodies (P = 0.02), and antibodies to Ro (SS-A) (P = 0.00006), and with hypocomplementemia (P = 0.03). The differential association of the 2 types of IVD with serologic reactivity and hypocomplementemia suggests that there may be basic differences in the immunopathogenesis of these 2 forms of IVD in Sjogren's syndrome.Inflammatory vascular disease (IVD) is increasingly being recognized as a complication of Sjogren's syndrome (SS) (1,2). Two distinct types of IVD have been observed (2): neutrophilic IVD (NIVD) and mononuclear IVD (MIVD). We previously reported a Publication #570 of the O'Neill Research Laboratories,
“…The results confirm the usefulness of the Dot-EIA for HBsAg detection in sera. The sensitivity of the technique was equal to the standard-EIA [4,5], whereas it offers some advantages over standard EIA. Antiserum absorption to the well surface must be performed with overnight incubation for the standard EIA.…”
“…Serum albumin was quantified utilizing the technique with enhanced specificity of bromocresol green colorimetric assay (Diamond Diagnostics Kit, Germany) [ 25 ]. Electrochemiluminescence immunoassay (ECLA) on COBAS immunoassay analyzer was employed for assessing HCV antibody (anti-HCV) [ 26 ], while HBsAg was detected using Sorin Biomedica Co. kit (Italy) [ 27 ]. AFP was measured by enzyme-linked immunosorbent assay (ELISA) (IMMULITE 1000 system by a kit provided by Siemens Medical Solutions Diagnostics, USA) [ 28 ].…”
Background and aim
Hepatocellular carcinoma (HCC) is a major health burden globally. Dysregulation of miRNA 148a-3p is engaged in carcinogenesis. TGF-β is a profibrogenic cytokine. This study assesses the expression level of miRNA 148a-3p and its relationship with serum TGF-β1 and fibrosis index based on four factors (FIB-4) in Egyptian patients with HCV-associated HCC.
Subjects
and Methods: The study included 72 HCC patients with HCV, 48 HCV cirrhotic patients, and 47 healthy controls. Serum TGF-β1 was assessed by ELISA and the expression of miRNA 148a-3p was measured by RT-PCR.
Results
Patients with HCC had lower plasma miRNA 148a-3p, higher serum TGF-β1, and higher FIB-4 levels than patients with cirrhosis and controls. miRNA 148a-3p discriminated HCC either from control (AUC: 0.997, 95.83% sensitivity, 85.11% specificity) or from cirrhosis (AUC: 0.943, 91.67% sensitivity, 81.25% specificity). Moreover, it distinguished metastatic from nonmetastatic patients (AUC: 0.800, 88.89% sensitivity, 60.0% specificity). The decreased miRNA 148a-3p and the increased TGF-β1 levels were related to distant metastasis, multinodular lesions, advanced TNM stage, and BCLC score (C). A negative correlation between miRNA 148a-3p and each of FIB-4 and TGF-β1 was detected. The decreased miRNA 148a-3p was associated with poor overall survival and poor progression-free survival.
Conclusion
An inverse relationship between miRNA 148a-3p and both TGF-β1 and FIB-4 was observed, which could be involved in HCC pathogenesis. Moreover, this miRNA is a potential diagnostic and prognostic biomarker for HCC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.